HomeEPRX • TSE
add
Eupraxia Pharmaceuticals Inc
Previous close
$7.57
Day range
$7.32 - $7.50
Year range
$3.07 - $8.13
Market cap
264.50M CAD
Avg Volume
29.62K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.26M | 26.07% |
Net income | -8.74M | -45.51% |
Net profit margin | — | — |
Earnings per share | -0.26 | -11.41% |
EBITDA | -8.23M | -25.98% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.77M | -15.23% |
Total assets | 23.60M | -5.52% |
Total liabilities | 2.62M | -77.50% |
Total equity | 20.98M | — |
Shares outstanding | 35.96M | — |
Price to book | -29.12 | — |
Return on assets | -78.22% | — |
Return on capital | -85.91% | — |
Cash Flow
Net change in cash
(USD) | Jun 2025info | Y/Y change |
---|---|---|
Net income | -8.74M | -45.51% |
Cash from operations | -8.32M | -8.05% |
Cash from investing | -166.22K | -1,041.14% |
Cash from financing | 239.78K | 105.31% |
Net change in cash | -7.69M | 38.93% |
Free cash flow | -5.63M | 0.48% |
About
Founded
2011
Headquarters
Website
Employees
33